No association between human parvovirus B19 and testicular germ cell cancer

Journal of General Virology

Volumn 83, Issue 9, 2002, Pages 2321-2324

  Tolfvenstam, Thomas ^a   Papadogiannakis, N ^a   Andersen, A ^a   Akre, O ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSPHINGOLIPID; VIRUS DNA; VIRUS RECEPTOR;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER CELL; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; DOSE RESPONSE; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; PARVOVIRUS; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEROLOGY; TESTIS CANCER;

DNA VIRUSES; PARVOVIRUS;

EID: 0036714729     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-83-9-2321     Document Type: Article

References (22)

1. Testicular cancer in nine northern European countries
2. Epstein-Barr virus and cytomegalovirus in relation to testicular-cancer risk: A nested case-control study
3. An outbreak of erythema infectiosum associated with human parvovirus infection
4. Persistent B19 parvovirus infection in pediatric malignancies
5. Erythrocyte P antigen: Cellular receptor for B19 parvovirus
6. The prevalence of antibody to human parvovirus B19 in England and Wales
7. Multiple glycosphingolipids determine the tissue tropism of parvovirus B19
8. Parvovirus B19 is associated with benign testes as well as testicular germ cell tumours
9. HLA class II gene polymorphism: DNA typing, evolution and relationship to disease susceptibility
10. Persistence of parvovirus B19 DNA in testis of patients with testicular germ cell tumours
11. Experiences of the Janus Serum Bank in Norway
12. Chronic bone marrow failure due to persistent B19 parvovirus infection
13. Clinical and laboratory findings in immunocompetent patients with persistent parvovirus B19 DNA in bone marrow
14. Clinical and histopathological features of parvovirus B19 infection in the human fetus
15. Epidemiologic comparison of cancer of the testis and Hodgkin's disease among young males
16. Changes in glycolipid expression in human testicular tumor
17. Glycolipids of human primary testicular germ cell tumours
18. The 3′ untranslated region of the B19 parvovirus capsid protein mRNAs inhibits its own mRNA translation in nonpermissive cells
19. Frequency of human parvovirus B19 infection in intrauterine fetal death
20. Recombinant human parvovirus B19 vectors: Erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells
21. Glycolipids of germ cell tumors: Extended globo-series glycolipids are a hallmark of human embryonal carcinoma cells
22. Hematologic and hematopoietic consequences of B19 parvovirus infection